Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00204880 · ClinicalTrials.gov registry record
Aging and Cancer Effects (ACE) Study
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 34
- Enrollment target
NCT00204880: Completed study, sponsored by University of Wisconsin, Madison.
NCT00204880 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 34 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00204880 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
Study Summary
Hypotheses: 1. Subjective self-reported data can be used to accurately reflect functioning across the 5 key domains. 2. Cancer and its various treatment modalities will exert detrimental effects on the 5 key domains in older adults with cancer. 3. Some aspect of baseline patient characteristic will be predictive of cancer-related outcomes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2005-02 |
| Est. Completion | 2009-12 |
What the finished NCT00204880 record still lists
NCT00204880 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 34 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00204880 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00204880 about?
NCT00204880 is a clinical study titled "Aging and Cancer Effects (ACE) Study". Hypotheses: 1. Subjective self-reported data can be used to accurately reflect functioning across the 5 key domains. 2. Cancer and its various treatment modalities will exert detrimental effects on the 5 key domains in older adults with cancer. 3. Some aspect of baseline patient characteristic will...
What is the current status of trial NCT00204880?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2005-02. Estimated completion is 2009-12.
Who is sponsoring clinical trial NCT00204880?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia